GENE ONLINE|News &
Human Trial Data Pushes Longevity Science Beyond the Mouse Model Era
The global population aged 65 years and older is expected to double to approximately 1.6 billion by 2050, making healthy aging one of healthcare's fastest-growing priorities. Image: Shutterstock
Four mechanisms now carry real human data instead of mouse studies alone. Together they explain why regulators, and Big Pharma, are treating aging biology as druggable rather than theoretical. For most of the past decade, longevity science lived in mice. Reprogramming reversed markers of aging in rodents; senolytics cleared zombie cells in petri dishes; rapamycin … Human Trial Data Pushes Longevity Science Beyond the Mouse Model Era Read More » This post is only available to members.
It's free! Log in now to read
LATEST
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
